Cellebrite DI Ltd. director Utsumi Ryusuke received 15,190 shares through an award or grant on September 17, 2026, according to an insider-filing summary from the SEC. The company trades under the ticker CLBT.

The source identifies the report as a Form 4 insider filing. Its supplied publication timestamp is September 30, 2026, at 00:40:39 UTC. That timestamp establishes when the source item was published; the supplied material does not separately confirm the filing’s submission date.

What the transaction shows

The reported transaction was a receipt of shares classified as an award or grant. That distinction matters when describing the event: the summary does not identify an open-market purchase or a sale by Utsumi.

The share count is 15,190, and the transaction date is September 17. Utsumi’s listed role is director at Cellebrite. Those details establish the recipient, company, transaction category and amount, but they do not establish a dollar value for the award.

The summary also flags the transaction as having no Rule 10b5-1 plan. That is a reported characteristic of this transaction. It does not, by itself, explain why the shares were awarded or establish anything about Utsumi’s other transactions.

What remains unconfirmed

The supplied information does not state a share price, vesting schedule or the specific terms governing the grant. It also does not provide Utsumi’s total holdings after the transaction or show how this award compares with any earlier compensation.

Analysis: The filing is useful as a record of a director’s reported share receipt. An award or grant alone is insufficient evidence of the director’s view on CLBT’s valuation, and the supplied facts do not support a conclusion about the company’s financial performance.

What to watch

The full filing would be the next source to check for the submission date, transaction footnotes, ownership totals and any stated award conditions. Until those details are available, the supported account remains a 15,190-share award or grant to a Cellebrite director.